BRIEF-Clovis oncology said to weigh sale of $2 bln biotech firm - Bloomberg
September 17, 2013 at 14:03 PM EDT
Sept 17 () - Clovis Oncology Inc, a developer of cancer treatments whose value has more than tripled this year, is exploring strategic options including a sale of the company, Bloomberg reported, citing people with knowledge of the matter.